Polar Cptl Glbl Hlthcare Sel I Acc
Healthcare and BiotechnologyPricing frequency
Daily
Dealing cut off time
13:45
Type
OEIC
Yield
–
NAV
£20.02
Income frequency
-
Ongoing charge
0.8%
Latest actual NAV date
12-11-2026
ISIN
IE00BPRBXV28
UCITS
Yes
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 30/09/2026 | % of assets |
|---|---|
| Johnson & Johnson | 9.71 |
| Eli Lilly and Co | 9.14 |
| UnitedHealth Group Inc | 6.01 |
| Roche Holding AG Ordinary Shares new | 5.33 |
| Teva Pharmaceutical Industries Ltd | 4.95 |
| Danaher Corp | 4.83 |
| Abbott Laboratories | 4.39 |
| AstraZeneca PLC | 3.87 |
| Agilent Technologies Inc | 3.46 |
| IQVIA Holdings Inc | 3.21 |
Investment objective
The Fund’s investment objective is to achieve long term capital appreciation. The Fund will seek to achieve its investment objective by investing in a globally diversified portfolio of healthcare companies.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.